The in-vitro effects of new quinolones and oral cephem antibiotics in various combinations on 26 strains of clinically isolated Serratia marcescens were assessed. The in-vitro activities of ofloxacin and ciprofloxacin in combination with either cefpodoxime or cefcamate were evaluated by the chequerboard titration method. These combinations showed synergistic and additive effects against most of the 5. marcescens tested but no antagonism was observed.
Introduction
Following significant development of the quinolone group of antibiotics in recent years, they are now widely used. However, because of the increase in incidence of Staphylococcus aureus and Pseudomonas aeruginosa resistant to new quinolones and the frequent appearance of Serratia marcescens and Bacteroides fragilis resistant to ofloxacin (Goto et al., 1990) , the reduction in efficacy of antibiotics against these bacteria has become a problem.
Synergy between new quinolones and aminoglycoside antibiotics has been reported, although no such effect was seen with combinations of new quinolones and /Mactam antibiotics (Lewin & Smith, 1989) . There have also been reports about synergic effects of new quinolones and /Mactam antibiotics (Haller, 1986) . In these studies, the /Mactam antibiotics used were almost entirely parenteral drugs. In this paper, we studied the in-vitro effects of combinations of oral cephem antibiotics (cefpodoxime and cefcamate) and new quinolones (ofloxacin and ciprofloxacin) against S. marcescens.
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Materials and methods

Bacterial strains and antibacterial agents
Twenty-six clinical isolates of S. marcescens were used. The antibacterial agents used were kindly provided by their respective manufacturers: ofloxacin (Daiichi Pharmaceutical Co., Tokyo, Japan), ciprofloxacin (Bayer Yakuhin, Osaka, Japan), cefpodoxime (Sankyo Co., Tokyo, Japan), cephaloridine (Shionogi & Co., Osaka, Japan), cefcamate (Shionogi & Co., Osaka, Japan), and cefmetazole (Sankyo Co., Tokyo, Japan).
Chequerboard assays
Chequerboard assays were performed by the agar dilution method with heart infusion agar (HIA, Nissui, Japan). The MIC was measured in accordance with the method recommended by the Japan Society of Chemotherapy (Committee for Revision of MIC Determination Method, 1981), using an inoculum size lO'cfu/mL. For evaluation of the effects of the various agents in combination, the minimum fractional inhibitory concentration index (minimum FIC index) was calculated (Haller, 1986) .
Time-kill curves
Bactericidal activities of each antibacterial agent alone and in two-drug combinations on S. marcescens F0046 and F0036 were examined. Antibacterial agents were added to logarithmic cultures in heart infusion broth (HIB, Nissui) to achieve the desired combinations and samples were obtained after 0, 1, 2, and 4 h of incubation to determine viable counts.
fi-Lactamase induction studies
The effect of ciprofloxacin in combination with cefmetazole on /Mactamase production was studied in S. marcescens F0046 in the logarithmic growth phase. Cefmetazole (1 mg/L) alone and in combination with ciprofloxacin (0.1 mg/L) were added and the incubation was continued for a further 60 min. The /Mactamase activity was then determined by the UV method as reported previously (Araki et al., 1988) . Cephaloridine was used as a substrate in /Mactamase assay.
Results
Chequerboard studies
The effects of various combinations of ciprofloxacin-cefpodoxime, ciprofloxacin-cefcamate, ofloxacin-cefpodoxime, and onoxacin-cefcamate on 26 strains of S. marcescens were studied using the chequerboard assay. A fractional inhibitory concentration (FIC) index of ^0.5 was scored as synergy, 0.5 to ^1.0 as an additive effect, > 1.0 to ^2.0 as indifference and >2 as antagonism (Table) . MICs of ofloxacin, ciprofloxacin, cefpodoxime, and cefcamate on 5. marcescens used were 100-0.10, 50-0.05, 100-0.39, 12.5-1.56 mg/mL, respectively. All of these combinations were synergistic or additive for most of the isolates tested. The percentage of strains showing synergy and additive actions against the combinations of ciprofloxacin and /Mactam antibiotics ranged from 26.9-42.3% and 57.7-69.2%. The combinations of /Mactam antibiotics with ofloxacin showed the same tendencies as those with ciprofloxacin. No antagonistic effects (>2.0) were observed in these combinations.
Time-kill curves
To confirm the findings of the chequerboard assays with the quinolone-/?-lactam combination, time-kill curves were established. The bactericidal effects were examined on two representative isolate, F0046 and F0036, on which a synergic effect was observed. The minimum FIC index for these isolates was 0.25-0.5 for ofloxacin-cefpodoxime and ofloxacin-cefcamate combinations, and 0.31-0.5 for ciprofloxacin-cefpodoxime and ciprofloxacin-cefcamate combinations. The MIC of ciprofloxacin and cefpodoxime against S. marcescens F0046 and FOO36 were 0.2, 6.25, 3.13 and 25 mg/L, respectively. To detect potential synergic drug interactions, lower concentrations of each compound which exhibited a bacteriostatic effect on both isolates when tested alone, were tested. for ofloxacin, a similar pattern was also obtained. These combined effects of ciprofloxacin and cefpodoxime against S. marcescens F0046 were also investigated when ciprofloxacin was followed by cefpodoxime with some time lag and vice versa. As shown in Figure 2 , when cefpodoxime was added at 1 or 2 h intervals after the addition of ciprofloxacin, bactericidal synergic actions between the two drugs were observed, as was the case for simultaneous addition. This synergic effect was observed even when cefpodoxime was added 3 h after exposure to ciprofloxacin. On the other hand, when ciprofloxacin was added at 1, 2, or 3h after the addition of cefpodoxime, the bactericidal action was weaker than that observed by simultaneous addition (Figure 3) .
Effect of ciprofloxacin on fi-lactamase induction by cefmetazole
The effect of cefmetazole in combination with ciprofloxacin on /Mactamase production was studied in S. marcescens F0046 (Figure 4) . The /?-lactamase activity of normal F0046 cells was 0.0111 U/mg of protein. Cefmetazole alone showed a small inductive effect (0.0125 U/mg of protein) for this strain. In comparison with cefmetazole alone, induction of /?-lactamase by a combination of cefmetazole and ciprofloxacin resulted in a moderate increase (0.018 U/mg of protein).
Discussion
Aminoglycoside antibiotics have been reported to enhance the bactericidal activity of new quinolones, whereas /Mactam antibiotics had no such effect on the bactericidal activity of these agents (Lewin & Smith, 1989) . However, there have been reports of synergy between new quinolones and several parenteral /Mactam antibiotics (Haller, 1986) , and more recent reports have indicated in-vivo synergic effects against quinolone-resistant P. aeruginosa (Nakamura et al., 1989) , and apparent synergy in clinical use (Shishido et al., 1992) .
In this study, we demonstrated the in-vitro synergy between new quinolones and oral cephem antibiotics against S. marcescens. This synergic effect was also confirmed by observation of morphological changes with electron microscopy (data not shown), as well as by the chequerboard titration results and time-kill studies.
New quinolones showed the greatest bactericidal effects when combined simultaneously with /Mactam antibiotics. In parallel with this, the effects of new quinolones followed with some time lag by /Mactam antibiotics and vice versa were also investigated. Combinations of new quinolones first and /Mactam antibiotics later showed greater bactericidal effects than when these agents were added in the reverse order. This synergy was supported by results of the experiments to determine the induction of /Mactamase and the incorporation of new quinolones into the cells (data not shown).
It has been reported that in E. coli, quinolones interact with the outer membrane as chelating agents, raising the permeability of the outer membrane to /Mactam antibiotics (Chapman & Georgopapadakou, 1988) .
The mechanism by which such combinations achieve synergy is believed to be the facilitation of entry of /Mactam antibiotics into cells after partial disruption of the cell wall through the action of new quinolones.
